Two SMA Drugs Move to Routine NHS Funding

NICE has recommended routine NHS access to nusinersen and risdiplam for spinal muscular atrophy, ending time-limited managed access schemes in place since 2019.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/two-sma-drugs-move-routine-nhs-funding-2026a1000fnk?src=rss

Author :

Publish date : 2026-05-14 13:32:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Two SMA Drugs Move to Routine NHS Funding

Stress and Neighborhood Support Affect Sleep Among Teens

RFK Jr. Aide Quits in Protest; ICE Releases Doctor; Osteoporosis Tied to Mortality

Related Posts

Hantavirus Risk to US Public Remains Low, CDC Says

GLP-1s and Hepatic Events; ‘Shame, Taboo, Hygiene’; Treating Late-Onset IBD

Nurse Killed in Hospital Parking Lot; Deadly Cosmetic Surgery Suit; EHR Lawsuit

Oncologist Who Cared for Hantavirus Patients on Ship Leaves Medical Isolation Unit

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

Two New Physician Social Media Platforms Come Online

Hantavirus Risk to US Public Remains Low, CDC Says

GLP-1s and Hepatic Events; ‘Shame, Taboo, Hygiene’; Treating Late-Onset IBD

Nurse Killed in Hospital Parking Lot; Deadly Cosmetic Surgery Suit; EHR Lawsuit

Oncologist Who Cared for Hantavirus Patients on Ship Leaves Medical Isolation Unit

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

Two New Physician Social Media Platforms Come Online

Will burying dead trees after a wildfire keep their carbon locked up?

On the Horizon: Dry Eye in Focus at ARVO 2026

Categories

Archives